-
ACLA Submits Comments on the CDC’s NCVHS ICD-11 RFI
-
ACLA Submits Comments on Palmetto Special Stains/IHC Proposed LCD
-
Letter to ONDCP on NCCI Edits for Drug Testing
-
ACLA Submits Comments on Senate HELP Committee RFI on Reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
-
Letter from Leading Patient Advocacy Organizations on Passing the Saving Access to Laboratory Services Act
-
Letter from Leading Provider Organizations on Passing the Saving Access to Laboratory Services Act
-
ACLA Submits Comments on Proposals for Updating OMB’s Race and Ethnicity Statistical Standards
-
ACLA Submits Comments to House Health Subcommittee on Building a Stronger Health Workforce
-
ACLA Response to Senate HELP RFI on PAHPA
-
ACLA Submits Comments to NIST on Cybersecurity of Genomic Data
